BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30544235)

  • 1. Molecular Mechanisms in Skeletal Muscle Underlying Insulin Resistance in Women Who Are Lean With Polycystic Ovary Syndrome.
    Hansen SL; Svendsen PF; Jeppesen JF; Hoeg LD; Andersen NR; Kristensen JM; Nilas L; Lundsgaard AM; Wojtaszewski JFP; Madsbad S; Kiens B
    J Clin Endocrinol Metab; 2019 May; 104(5):1841-1854. PubMed ID: 30544235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.
    Højlund K; Glintborg D; Andersen NR; Birk JB; Treebak JT; Frøsig C; Beck-Nielsen H; Wojtaszewski JF
    Diabetes; 2008 Feb; 57(2):357-66. PubMed ID: 17977950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
    Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
    Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired insulin activation and dephosphorylation of glycogen synthase in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.
    Glintborg D; Højlund K; Andersen NR; Hansen BF; Beck-Nielsen H; Wojtaszewski JF
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3618-26. PubMed ID: 18544618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The determinants of insulin sensitivity, β-cell function, and glucose tolerance are different in patients with polycystic ovary syndrome than in women who do not have hyperandrogenism.
    Luque-Ramírez M; Alpañés M; Escobar-Morreale HF
    Fertil Steril; 2010 Nov; 94(6):2214-21. PubMed ID: 20097337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
    Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Wolczynski S; Gorska M
    Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation Triggered by Saturated Fat Ingestion Is Linked to Insulin Resistance and Hyperandrogenism in Polycystic Ovary Syndrome.
    González F; Considine RV; Abdelhadi OA; Acton AJ
    J Clin Endocrinol Metab; 2020 Jun; 105(6):e2152-67. PubMed ID: 32140727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance.
    Ciaraldi TP; Aroda V; Mudaliar S; Chang RJ; Henry RR
    J Clin Endocrinol Metab; 2009 Jan; 94(1):157-63. PubMed ID: 18854391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of insulin resistance in lean women with polycystic ovary syndrome.
    Morciano A; Romani F; Sagnella F; Scarinci E; Palla C; Moro F; Tropea A; Policola C; Della Casa S; Guido M; Lanzone A; Apa R
    Fertil Steril; 2014 Jul; 102(1):250-256.e3. PubMed ID: 24825420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin concentration is associated with muscle insulin sensitivity, AMPK phosphorylation, and ceramide content in skeletal muscles of men but not women.
    Høeg LD; Sjøberg KA; Lundsgaard AM; Jordy AB; Hiscock N; Wojtaszewski JF; Richter EA; Kiens B
    J Appl Physiol (1985); 2013 Mar; 114(5):592-601. PubMed ID: 23305978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating and cellular adiponectin in polycystic ovary syndrome: relationship to glucose tolerance and insulin action.
    Aroda V; Ciaraldi TP; Chang SA; Dahan MH; Chang RJ; Henry RR
    Fertil Steril; 2008 May; 89(5):1200-1208. PubMed ID: 17706206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperandrogenism Enhances Muscle Strength After Progressive Resistance Training, Independent of Body Composition, in Women With Polycystic Ovary Syndrome.
    Kogure GS; Silva RC; Miranda-Furtado CL; Ribeiro VB; Pedroso DCC; Melo AS; Ferriani RA; Reis RMD
    J Strength Cond Res; 2018 Sep; 32(9):2642-2651. PubMed ID: 29927897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional and Epigenetic Changes Influencing Skeletal Muscle Metabolism in Women With Polycystic Ovary Syndrome.
    Nilsson E; Benrick A; Kokosar M; Krook A; Lindgren E; Källman T; Martis MM; Højlund K; Ling C; Stener-Victorin E
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4465-4477. PubMed ID: 30113663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of caloric intake timing on insulin resistance and hyperandrogenism in lean women with polycystic ovary syndrome.
    Jakubowicz D; Barnea M; Wainstein J; Froy O
    Clin Sci (Lond); 2013 Nov; 125(9):423-32. PubMed ID: 23688334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS.
    Shorakae S; Ranasinha S; Abell S; Lambert G; Lambert E; de Courten B; Teede H
    Clin Endocrinol (Oxf); 2018 Nov; 89(5):628-633. PubMed ID: 29992612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity.
    Baillargeon JP; Carpentier A
    Fertil Steril; 2007 Oct; 88(4):886-93. PubMed ID: 17559844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal metabolic flexibility despite insulin resistance women with polycystic ovary syndrome.
    Adamska A; Karczewska-Kupczewska M; Nikołajuk A; Otziomek E; Górska M; Kowalska I; Strączkowski M
    Endocr J; 2013; 60(9):1107-13. PubMed ID: 23801024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal muscle mitochondrial function in polycystic ovarian syndrome.
    Rabøl R; Svendsen PF; Skovbro M; Boushel R; Schjerling P; Nilas L; Madsbad S; Dela F
    Eur J Endocrinol; 2011 Oct; 165(4):631-7. PubMed ID: 21798960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.